Fibrogen Inc financial data

Symbol
FGEN on Nasdaq
Industry
Pharmaceutical Preparations
Location
350 Bay Street, Suite 100 #6009, San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 141 % -22.6%
Quick Ratio 15.7 % -11.3%
Debt-to-equity -230 % +67.5%
Return On Equity 59 % -87.5%
Return On Assets -36.2 % +34.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 101M shares +2.47%
Common Stock, Shares, Outstanding 101M shares +2.47%
Entity Public Float 262M USD -73.2%
Common Stock, Value, Issued 1.01M USD +2.54%
Weighted Average Number of Shares Outstanding, Basic 101M shares +2.31%
Weighted Average Number of Shares Outstanding, Diluted 101M shares +2.31%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 180M USD +16.2%
Cost of Revenue 41.6M USD +127%
Research and Development Expense 146M USD -50.2%
Costs and Expenses 293M USD -34.7%
Operating Income (Loss) -113M USD +61.6%
Nonoperating Income (Expense) 7.59M USD -14.8%
Income Tax Expense (Benefit) -137K USD -542%
Net Income (Loss) Attributable to Parent -122M USD +58.6%
Earnings Per Share, Basic -1.22 USD/shares +60.1%
Earnings Per Share, Diluted -1.22 USD/shares +60.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 131M USD +8.34%
Accounts Receivable, after Allowance for Credit Loss, Current 29M USD -8.41%
Inventory, Net 23.9M USD -41.2%
Other Assets, Current 3.19M USD
Assets, Current 245M USD -32.8%
Property, Plant and Equipment, Net 7.6M USD -47.6%
Operating Lease, Right-of-Use Asset 2.09M USD -97.1%
Other Assets, Noncurrent 2.73M USD -30.9%
Assets 264M USD -42.6%
Accounts Payable, Current 9.24M USD -51.9%
Employee-related Liabilities, Current 6.14M USD -56.3%
Accrued Liabilities, Current 151M USD -11.6%
Contract with Customer, Liability, Current 28.9M USD +294%
Liabilities, Current 191M USD -9.02%
Contract with Customer, Liability, Noncurrent 126M USD -18.1%
Operating Lease, Liability, Noncurrent 707K USD -99%
Other Liabilities, Noncurrent 837K USD -80.3%
Liabilities 466M USD -19%
Accumulated Other Comprehensive Income (Loss), Net of Tax -5.63M USD +18.7%
Retained Earnings (Accumulated Deficit) -1.91B USD -6.82%
Stockholders' Equity Attributable to Parent -244M USD -55%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -223M USD -63.3%
Liabilities and Equity 264M USD -42.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -59.3M USD +41.6%
Net Cash Provided by (Used in) Financing Activities -165K USD -101%
Net Cash Provided by (Used in) Investing Activities 51.3M USD -50.4%
Common Stock, Shares Authorized 225M shares 0%
Common Stock, Shares, Issued 101M shares +2.47%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.95M USD -124%
Deferred Tax Assets, Valuation Allowance 535M USD +11.9%
Deferred Tax Assets, Gross 549M USD +11.6%
Operating Lease, Liability 2M USD -97.6%
Depreciation 810K USD -68.1%
Payments to Acquire Property, Plant, and Equipment 29K USD -95.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -120M USD +59%
Lessee, Operating Lease, Liability, to be Paid 90.3M USD -12.7%
Property, Plant and Equipment, Gross 150M USD +0.52%
Operating Lease, Liability, Current 1.29M USD -89.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 18.8M USD +8.87%
Lessee, Operating Lease, Liability, to be Paid, Year One 17.6M USD +26.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.74M USD -28.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 18.1M USD -1.98%
Deferred Tax Assets, Operating Loss Carryforwards 175M USD +5.13%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 125M shares 0%
Unrecognized Tax Benefits 81M USD +11.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 18.5M USD +2.64%
Additional Paid in Capital 1.67B USD +2.08%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 14M USD -0.27%
Interest Expense 19.8M USD +71.3%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%